Piotr Damianski

Lodz, LD 90419, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Organ Involvement and Constitutional Symptoms in Idiopathic Hypereosinophilic Syndrome: A 72-Patient Single-Centre Cohort.

Organ Involvement and Constitutional Symptoms in Idiopathic Hypereosinophilic Syndrome: A 72-Patient Single-Centre Cohort.

Journal: Journal of clinical medicine

Published: May 14, 2026

Impact of IL-5 Pathway Inhibition on Circulating Eosinophil- and Remodeling-Related Biomarkers in Severe Eosinophilic Asthma.

Impact of IL-5 Pathway Inhibition on Circulating Eosinophil- and Remodeling-Related Biomarkers in Severe Eosinophilic Asthma.

Journal: Journal of asthma and allergy

Published: May 06, 2026

NEXThaler® in Focus: Evaluating Inhalers' Expectations, Experiences, and Preferences Across Patients, General Practitioners, and Specialists.

NEXThaler® in Focus: Evaluating Inhalers' Expectations, Experiences, and Preferences Across Patients, General Practitioners, and Specialists.

Journal: Journal of clinical medicine

Published: September 28, 2025

Correction: Damiański et al. Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study. Biomedicines 2025, 13, 887.

Correction: Damiański et al. Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study. Biomedicines 2025, 13, 887.

Journal: Biomedicines

Published: September 17, 2025

Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study.

Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study.

Journal: Biomedicines

Published: February 22, 2025

Clinical profiles of patients referred for biological therapy and major limitations in the qualification paths in a specialist asthma centre.

Clinical profiles of patients referred for biological therapy and major limitations in the qualification paths in a specialist asthma centre.

Journal: Postepy dermatologii i alergologii

Published: August 23, 2022

Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives.

Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives.

Journal: Frontiers in immunology

Published: July 01, 2022

Improving the risk-to-benefit ratio of inhaled corticosteroids through delivery and dose: current progress and future directions.

Improving the risk-to-benefit ratio of inhaled corticosteroids through delivery and dose: current progress and future directions.

Journal: Expert opinion on drug safety

Published: November 01, 2021

Generalized emphysema and chronic obstructive pulmonary disease in a farmer, non-smoker - the more we seek, the more we find.

Generalized emphysema and chronic obstructive pulmonary disease in a farmer, non-smoker - the more we seek, the more we find.

Journal: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego

Published: September 02, 2019

Showing 1-9 of 9

Last Updated: 09/26/2026